Malignant hyperthermia is an inherited skeletal muscle disorder. A malignant hyperthermia crisis is triggered by volatile anaesthetics and many drugs and has an extremely high mortality rate when not treated. This paper describes the aetiology, clinical manifestations and treatment of this disease and outlines the correct procedure for patients who are susceptible to a malignant hyperthermic crisis. Epidemiology Malignant hyperthermia (MH) is a genetically transmitted disease of the skeletal muscular system characterized by an increase in muscle metabolism in response to certain drugs and anaesthetic agents- it may also occur as a response to stress. The disorder has been found to occur in both humans and pigs. 1 MH is rare in humans below ...
Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia...
Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane, enfluran...
Patients with Duchenne and Becker muscular dystrophy suffer from a progressive deterioration in musc...
Malignant hyperthermia (MH) is an uncommon, lifethreatening pharmacogenetic disorder of the skeletal...
Malignant hyperthermia (MH) is a rare and life-threatening pharmacogenetic disorder triggered by vol...
Contains fulltext : 19527.pdf (publisher's version ) (Open Access)In this thesis t...
Malignant hyperthermia (MH) is a relatively rare, but potentially lethal genetic disorder. That dise...
SummaryContentMalignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder that affe...
Background: Malignant hyperthermia susceptibility (MHS) is a skeletal muscle disorder leading to pot...
Introduction Malignant Hyperthermia (MH) is an inherited hypermetabolic syndrome triggered by exposu...
Objective The identification of a predisposition toward malignant hyperthermia (MH) as a risk factor...
Early studies indicated that the pharmacogenetic disorder, malignant hyperthermia (MH), was inherite...
Malignant Hyperthermia (MH), is a rare emergency that happened during General Anesthesia. In Albania...
Background: Malignant hyperthermia (MH) is a rare pharmacogenetic disorder which is characterized by...
MALIGNANT hyperthermia (MH) is a rare autoso-mal dominant genetic disorder of the skeletal mus-cle, ...
Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia...
Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane, enfluran...
Patients with Duchenne and Becker muscular dystrophy suffer from a progressive deterioration in musc...
Malignant hyperthermia (MH) is an uncommon, lifethreatening pharmacogenetic disorder of the skeletal...
Malignant hyperthermia (MH) is a rare and life-threatening pharmacogenetic disorder triggered by vol...
Contains fulltext : 19527.pdf (publisher's version ) (Open Access)In this thesis t...
Malignant hyperthermia (MH) is a relatively rare, but potentially lethal genetic disorder. That dise...
SummaryContentMalignant hyperthermia (MH) is a potentially lethal pharmacogenetic disorder that affe...
Background: Malignant hyperthermia susceptibility (MHS) is a skeletal muscle disorder leading to pot...
Introduction Malignant Hyperthermia (MH) is an inherited hypermetabolic syndrome triggered by exposu...
Objective The identification of a predisposition toward malignant hyperthermia (MH) as a risk factor...
Early studies indicated that the pharmacogenetic disorder, malignant hyperthermia (MH), was inherite...
Malignant Hyperthermia (MH), is a rare emergency that happened during General Anesthesia. In Albania...
Background: Malignant hyperthermia (MH) is a rare pharmacogenetic disorder which is characterized by...
MALIGNANT hyperthermia (MH) is a rare autoso-mal dominant genetic disorder of the skeletal mus-cle, ...
Malignant hyperthermia manifests clinically as a hypermetabolic crisis when a malignant hyperthermia...
Malignant hyperthermia (MH) can develop after contact with volatile anesthetics (halothane, enfluran...
Patients with Duchenne and Becker muscular dystrophy suffer from a progressive deterioration in musc...